To determine whether the miRNA-34a/SIRT1/p53 signaling pathway is also associated with liver fibrosis in progressive NASH, its activation has been investigated in a carbon tetrachloride (CCl4)-induced rat liver fibrosis model. Here, TP53 is linked to metabolic dysfunction-associated steatohepatitis.